Caribou Biosciences focuses on allogeneic CAR-T therapies for hematological cancers and autoimmune diseases, leveraging its unique chRDNA genome-editing technology. In my view, CRBU's chRDNA platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback